Results 21 to 30 of about 23,012 (218)

Assessment of mumps-containing vaccine effectiveness by dose during 2006 to 2020 in Quzhou, China

Human Vaccines & Immunotherapeutics, 2022
Mumps cases were reported frequently when a routine dose measles–mumps–rubella(MMR) achieved high coverage in Quzhou. The supplementary immunization activities (SIA) using measles mumps (MM) was conducted to control mumps outbreaks.
Zhiying Yin, Tingcui Wen, Quanjun Fang, Canjie Zheng, Xiaoying Gong, Junji Li, Shuangqing Wang, Ziling Xiang   +7 more
doaj   +1 more source

Mumps-containing vaccine effectiveness during outbreaks in two schools in Guangdong, China, 2012

Western Pacific Surveillance and Response, 2012
Introduction: Mumps-containing vaccine was licensed in the 1990s in China with a single dose administered routinely to children aged 18–24 months since 2008.
Su Qi-ru, Luo Hui-ming, Hao Li-xin, Ma Chao, Wang Tao, Zhao Jin-kou, Wang Man   +6 more
doaj   +1 more source

Impact of vaccine effectiveness and coverage on preventing large mumps outbreaks on college campuses: Implications for vaccination strategy

Epidemics, 2022
Recent mumps outbreaks among highly vaccinated populations, including college students, have called into question the vaccine effectiveness (VE) of routine two-dose measles, mumps, and rubella (MMR2) immunization. We aimed to estimate the VE required for
Michael Melgar, Bryan Yockey, Mariel Asbury Marlow   +2 more
doaj   +1 more source

Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients

mBio, 2020
The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against coronavirus disease 2019 (COVID-19). Our aim was to determine whether any MMR IgG titers are inversely correlated with severity in recovered COVID-19 patients ...
Jeffrey E. Gold, William H. Baumgartl, Ramazan A. Okyay, Warren E. Licht, Paul L. Fidel, Mairi C. Noverr, Larry P. Tilley, David J. Hurley, Balázs Rada, John W. Ashford   +9 more
doaj   +1 more source

Safety and immunological effectiveness of the domestic combined trivaccine for the prevention of measles, rubella and mumps Vaktrivir^® in children 12 months and 6 years of age (results of a simple blind multicenter comparative randomized clinical trial)

Эпидемиология и вакцинопрофилактика, 2021
Relevanc. Measles, mumps and rubella, despite many years of vaccination, retain their epidemiological and social significance at the present time. The aim of the work is to study the safety and immunogenicity. Of the vaccine for the prevention of measles,
I. V. Feldblium, V. V. Romanenko, K. A. Subbotina, M. G. Menshikova, I. A. Okuneva, A. Y. Musikhina, T. E. Snitkovskaya, N. I. Marcovich, A. E. Ershov, D. M. Trofimov   +9 more
doaj   +1 more source

A mumps model with seasonality in China

Infectious Disease Modelling, 2017
Background: Mumps, an infectious viral disease, classically manifested by inflammation of salivary glands and is best known as a common childhood viral disease with no specific treatment.
Qianqian Qu, Cong Fang, Le Zhang, Wanru Jia, Jie Weng, Yong Li   +5 more
doaj   +1 more source

Effectiveness of an outbreak dose of mumps-containing vaccine in two First Nations communities in Northern Ontario, Canada

Human Vaccines & Immunotherapeutics, 2022
Between 18 Dec 2017 and 27 June 2018, a mumps outbreak occurred in two Canadian Indigenous communities. An outbreak dose of mumps-containing vaccine was offered as part of control measures.
Wallis Rudnick, Sarah Wilson, Jo Ann Majerovich, Michelle Haavaldsrud, Marene Gatali, Cai-Lei Matsumoto, Shelley Deeks   +6 more
doaj   +1 more source

Assessment of mumps-containing vaccine effectiveness during an outbreak: Importance to introduce the 2-dose schedule for China

Human Vaccines & Immunotherapeutics, 2018
Introduction: China has used 3 different mumps-containing vaccines (MuCV) since 1990: monovalent mumps vaccine, measles–mumps (MM) vaccine, and measles–mumps–rubella (MMR) vaccine, and one dose MuCV (using MMR at 18 months) has been included in the EPI ...
Chao Ma, Yan Liu, Jihai Tang, Haimei Jia, Wei Qin, Ying Su, Huaqing Wang, Lixin Hao   +7 more
doaj   +1 more source

Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute lymphoblastic leukemia

Revista Brasileira de Hematologia e Hemoterapia, 2012
OBJECTIVE: To evaluate viral vaccine antibody levels in children with acute lymphoblastic leukemia after chemotherapy and after vaccine booster doses.
Simone Santana Viana, Gustavo Santos Araujo, Gustavo Baptista de Almeida Faro, Lana Luíza da Cruz-Silva, Carlos André Araújo-Melo, Rosana Cipolotti   +5 more
doaj   +1 more source

MUMPS: ACHIEVEMENTS, PROBLEMS AND WAYS OF SOLUTION

Фармация и фармакология (Пятигорск), 2021
The aim. The article highlights the current state of the problem of mumps in the world and the Russian Federation.Materials and methods. The materials of the study were electronic resources WHO infection control, Cohrane, Elsevier, ScienceDirect, CDC ...
V. V. Semerikov, N. V. Yuminova, N. O. Postanogova, L. V. Sofronova   +3 more
doaj   +1 more source